Thermo Fisher Scientific offers industry-leading pharma services through our Patheon™ brand, offering an integrated global network of scientific, technical, regulatory, and quality experts who are committed to helping you deliver medicine to patients faster. We believe that doing this successfully not...
Thermo Fisher Scientific’s state-of-the-art contract API development and manufacturing facility in Cork supports our customers in bringing medicines to patients through the relentless application of science in process and analytical development. We take chemistry from laboratory-scale development through ...
When you require specialized, reliable, high-quality solutions, count on Thermo Fisher Scientific Services. Our portfolio of market-leading services can help you increase your lab’s productivity and efficiency with a comprehensive suite of services, customized just the way you need them. Our wide ...
Thermo Fisher Scientific 在生物制药/制药管线的每个阶,包括发现、开发、临床、生产和质量控制,都拥有创新的解决方案。我们深刻理解药品生产商面临的挑战,因而我们可以与药品生产商成为合作伙伴,缩短新一代药品的上市时间。 联系我们 下载宣传册 快速链接
Through Patheon pharma services, Thermo Fisher Scientific provides CDMO services for drug development, clinical trial logistics, and commercial manufacturing to customers.
Thermo Fisher Scientific Inc. and Innoforce announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022 and will ...
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022. ...
Thermo Fisher Scientific offers you the broadest set of biochemical fluorescent assays to address high-throughput screening, hit confirmation and lead optimization programs and are available as kits,customor bulk reagents. Organoids, spheroids & 3D cell culture ...
Thermo Fisher is a leading global provider of bioprocessing solutions. We simplify the development path and accelerate our customers’ innovations to bring therapies to patients, faster. With our comprehensive portfolio of products and services we are a dedicated partner throughout the biological drug ...
The GSK transaction, which is expected to be completed by the end of 2019, is subject to customary closing conditions, including regulatory approvals. Upon completion, the site will become part of Thermo Fisher's Pharma Services business within its Laboratory Products and Services Segment. ...